Clinical Trial Update: Phase I Clinical Trial to Evaluate the Safety and Tolerability of Ophtalmic Solution PRO-201 [Phase 1]

View source ↗

Summary

Phase I trial evaluating the safety and tolerability of the ophthalmic solution PRO-201 in myopia completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myopia

Drugs mentioned

• PRO-201

Snippet

Sponsor: Laboratorios Sophia S.A de C.V. | Conditions: Myopia | Phase 1 | Status: COMPLETED | Results posted: 2026-02-05